Abstract
This paper reviews the use of iron oxide nanoparticle-nanofibre composites in tissue engineering with a focus on the electrospinning technique. Electrospinning is an established method of scaffold fabrication offering a number of key advantages which include its facile nature, with electrospun materials offering a high surface area to volume ratio, potential for the release of drugs and antimicrobials, controllable fibre diameters and high porosity and permeability. A number of different techniques for the preparation of iron oxide nanoparticles including their functionalisation are discussed along with their applications in the biomedical field. The review then focusses on the fabrication of nanoparticlenanofibre composite scaffolds formed using electrospinning. The advantages and disadvantages of current fabrication techniques are discussed including the fabrication of nanofibres using pre-synthesised nanoparticles and post-treatment synthesised nanoparticles. We demonstrate that emerging in-situ synthesis techniques show promise by offering a reduced number of steps and simpler procedures for the production of magnetic scaffolds. These scaffolds have a number of applications in tissue engineering, allowing for improved bone and tissue repair.
Introduction
Tissue engineering has made great advances in recent years combining both engineering and biology to repair, replace or regenerate parts of or whole tissue(s). Naturally, the applications of such technologies in medical science have the potential to treat a wide range of conditions. Many fundamental components of biological systems, including the extracellular matrix, exist and function at the nanoscale with sizes measured in billionths of a metre. Thus, technologies that can create nanoscale materials are essential in shaping and controlling systems that are designed to mimic tissue chemical and physical environments.
Electrospinning is a fabrication technique that has become one the preferred jetting methodologies for the fabrication of tissue engineering scaffolds (1-3). It is an established method for fabrication of polymer constructs that offers many advantages to tissue engineering that include the formation of nanoscale fibres, 3 which are analogues to the extra cellular matrix (ECM), the molecular architecture that provides structure to the tissue. In addition, electrospinning methods allow the incorporation of biologically active moieties into the polymer construct rendering the scaffold 'smarter'. The improved functionality of scaffolds allowed by electrospinning coupled with recent advances in scale of manufacture have led to a resurgence of interest in electrospinning. The incorporation of nanoparticles within electrospun fibres is a further method by which improved functionality can be programmed into polymer nanofibers. A key example of such improved functionality is magnetic scaffolds, where iron oxide nanoparticles (IONPs) are incorporated into scaffold structures for applications in tissue engineering, drug delivery and wound healing. This review will firstly discuss tissue engineering scaffolds and the techniques used for their fabrication, and then review the applications of IONPs before focussing on the development of iron oxide nanoparticle-nanofibre composites using electrospinning and review their potential applications.
Tissue Engineering scaffolds
Tissue engineering scaffolds require four key properties to allow them to support the three-dimensional formation of viable tissue (4) . These are biocompatibility, biodegradability, tensile strength and scaffold architecture. The scaffold must provide a biocompatible 3D matrix supporting or enhancing cell proliferation and migration while allowing the uninhibited diffusion of nutrients and other cell media throughout the structure. It must also be compatible with the human body, without triggering an immune response when implanted. The material used must be biodegradable to allow the scaffold to degrade as the cells begin to form their own matrix. The mechanical properties of the scaffold should match that of the tissue in which the scaffold will be introduced (5) . For example, in tissue engineered cartilage and bone, the scaffold will require specific tensile and compression strengths to withstand the load placed upon it by the patient without "shielding" osteoblast cells causing bone resorption (6) . The overall scaffold architecture is also key, for example the axons of neurons require directional 4 growth and therefore scaffolds comprised of uniaxial fibre arrays have been shown to result in improved axonal outgrowth parallel to the direction of the fibres (7). This is also true for myocytes (8) . Finally, the overall nonwoven structure requires a high degree of porosity, with a sufficient minimum pore size to allow the proliferation of cells and diffusion of cell media, cell-signalling stimuli, waste products and other required substances (4) . Cell signalling, the communication between proximal cells, is also of great importance for tissue growth. It has been reported that porosity, pore size, interconnectivity and tensile strength are all important influences of cell signalling and differentiation (9) .
Several different methods exist to produce scaffolds for tissue engineering. Most common are jetting methodologies such as aerodynamically assisted jetting/threading, pressure assisted/driven jetting/spinning (10), laser guided writing (11), inkjet printing (12), electrospraying (13) and electrospinning (14) .
Laser guided writing and ink jet printing have historically dominated the field, contributing much to the recognition of jetting technologies and their application (10) . However, due to their micron-scale size fabrication limits which are much larger than the natural ECM they are designed to mimic, these technologies do not translate easily into the development of constructs for clinical application. Other methods such as electrospraying and electrospinning are currently undergoing a widespread revival of scientific investigation of chemical, physical and biological outputs achievable and are able to produce structures more similar in size to the natural ECM. These techniques have generated much scientific and commercial interest in fields such as tissue engineering, regenerative devices and drug delivery.
Electrospinning
The advantages of electrospinning for the fabrication of non-woven fibrous structures has meant that it has been applied in a diverse range of fields from regenerative medicine to filtration and water treatment (10, (14) (15) (16) (17) (18) (19) ). An electrospun scaffold can offer a number of desirable properties such as a high surface area to volume ratio, potential for the release of drugs and antimicrobials, 5 controllable fibre diameters, high porosity and permeability. In more recent years the emergence of new electrospinning technologies has ensured that fabrication is scalable and economically viable for high volume production. Electrospinning uses a high voltage power supply to create a large potential difference between a grounded "collector" structure and a polymer solution or melt being delivered at a constant rate through an aperture, such as a blunt end needle. As the voltage is increased the body of the polymer fluid becomes charged and electrostatic repulsion directly opposes surface tension, resulting in the normally spherical droplet at the aperture distending into a conical shape. This cone is referred to as the "Taylor" cone, after Sir Geoffrey Taylor who first mathematically modelled the phenomenon (20, 21) . At a critical voltage the electrostatic attractive force between the solution and the collector causes a jet of polymer solution to be expelled from the cone tip towards the grounded collector surface. This jet then undergoes a whipping instability and dries in flight as the solvent evaporates, depositing the nanofibres on the collector (14). (14) .
Despite the relative simplicity of the equipment involved, by carefully controlling processing parameters the fibre's diameters, orientations, total mat porosity and other properties can be controlled, allowing optimisation of the mat for a given application. In addition, the technique's ability to work with a wide variety of materials allows a range of specific biological, mechanical or chemical properties to be achieved (15) . Therefore by controlling solution properties such as the viscosity, conductivity, molecular weight and surface tension along with processing parameters such as the applied electrical field, distance from the syringe tip to the collector and flow rate of the polymer solution, a range of desirable characteristics can be attributed to the nanofibres (14) .
Further to these controllable variables it has been shown that by modifying the collector architecture, for example by using two parallel conductive substrates of varying gap size, fibres can be aligned uniaxially into arrays (22) . This alignment of fibres has led to anisotropic mat properties in terms of tensile strength as well as directional cell growth, as previously discussed. Further modifications to the collector have been illustrated to expand the possible fibre orientations including rotating drum electrode (23) and knife-edge collectors (24) . Furthermore, "coaxial" electrospinning allows for a more complex fibre architecture, forming a fibre comprised of two non-mixed materials in a core-sheath arrangement (25, 26) .
Although needle based electrospinning allows excellent control over both fibre diameter and their composition it has an extremely low throughput where basic systems are limited to flow rates of less than 0.5 mL per hour. A free-surface electrospinning arrangement such as the El Marco NanoSpider™ system is capable of forming fibres with throughput many hundreds of times greater than the conventional needle based electrospinning set up (27,28). In the free-surface electrospinning approach the spinning solution is simply held in a bath, rather 7 than being delivered through an aperture, with the whole bath then being connected to a high voltage power supply ( Figure 2 ). In the specific case of the NanoSpider™ a rotating metal mandrel is half-submerged in the bath to concentrate the electric field on the thin layer of polymer which coats the mandrel.
In this process many Taylor cones are formed on the surface of the polymer solution, and electrospinning upwards onto a collector above the bath. This increases the throughput of the process many hundreds of times above the conventional needle-based system, however much higher voltages, up to 82kV in the case of the NanoSpider™ are required and solution properties such as viscosity, conductivity and surface tension must be more tightly controlled (29) . This is due to requirement of the Taylor cone to form upwards and the inability to control the feed rate and subsequent Taylor cone formation. There is also an absence of a point at which to concentrate the electric field (such as in a blunt end needle) which results in a higher initiation voltage. Electrospun scaffolds have seen a vast amount of research in the tissue engineering field. This is due to the requirement of the scaffold to have an appropriate pore size and porosity to allow the proliferation of cells as well as a large surface area to volume ratio to promote cell adhesion, growth migration and differentiation (30) .
In a recent review, we discuss the importance of understanding the interactions between not only eukaryotic cells but also bacteria for the development of tissue engineering scaffolds as cells need to compete with bacteria in many environments therefore the ideal tissue engineering scaffold will promote cell adhesion while inhibiting bacterial cell adhesion (31) . Although there has been little research to date, interactions of bacteria with nanofibres and nano-structured surface have been shown to be similar. A smaller fibre diameter is favourable since scaffolds with nanofibre diameters smaller than the bacteria have been shown to be less susceptible to bacterial adhesion and fouling (31) . Furthermore, the inclusion of an active antimicrobial ingredient can further inhibit bacterial colonisation and aid in the promotion of cell adhesion.
Iron Oxide Nanoparticles
Iron oxide is known to exist in sixteen forms as oxides, hydroxides or oxidehydroxides (32) . There are six non-hydrated crystalline iron oxide phases which have been identified so far, which are classified according to the valence state of iron in their crystal structure (33) . Among these the most of interest in biomedical fields are magnetite (Fe3O4) and maghemite (γ-Fe2O3) due to their functionality and favourable magnetic properties (33) . Figure 2 shows the crystal structure and crystallographic data of hematite, magnetite and maghemite. Magnetite, Fe3O4, is a black ferromagnetic material with an inverse spinel structure. It contains both Fe 2+ and Fe 3+ . Maghemite, γ-Fe2O3, is a redish-brown ferromagnetic material which is 9 isostructural with magnetite, but with cation deficient sites. An important structural properties of both magnetite and maghemite is its crystal size. If the diameter of the nanoparticles are smaller than 20nm they display superparamagnetism, resulting in the particles showing no continuing magnetic interaction upon the removal of an external magnetic field (34) . Furthermore iron oxide has been reported as non-toxic at low doses, biodegradable and biocompatible (35) . Reprinted with permission from (36) .
Both magnetite and maghemite exhibit ferrimagnetism at room temperature. Many of the properties of IONPs are dependent on both their size and shape (32).
Nanoparticle Synthesis
A number of different synthesis techniques have been applied to produce magnetic iron oxide nanoparticles (IONPs) including co-precipitation, thermal decomposition, hydrothermal and solvothermal syntheses, sol-gel synthesis, microemulsion, ultrasound irradiation and biological synthesis. These methods include both aqueous and non-aqueous techniques with the former usually preferred due to the lower cost and sustainability (37) .
Co-precipitation and thermal decomposition are the most commonly applied methods for preparing iron oxide nanoparticle-nanofibre composites, particularly for post-treatment and in-situ synthesis techniques.
Co-precipitation
Co-precipitation is considered the most conventional method. Generally, a basic solution is prepared containing a 1:2 molar ratio of ferric and ferrous ions. A suitable reducing agent can be used leading to the reaction shown in equation 4.1.1.
Due to the nature of the technique, particle aggregation is a major drawback (38) .
To overcome this problem researchers have introduced surfactants and biomolecules into the process to reduce the likelihood of aggregation and maintain presented an in situ synthesis technique for the production of non-spherical magnetic iron oxide nanoparticles in a carboxyl functionalised polymer matrix (41).
Thermal Decomposition
Thermal decomposition is a particle formation technique with slower production rates than co-precipitation but offers more control over particle size and size 
Biomedical Applications
The biocompatibility and low toxicity of iron oxide nanoparticles makes them ideal candidates for applications in the biomedical field. It is established that the iron oxide nanoparticles themselves are biocompatible and are excreted naturally by the liver when released into the body at low doses (47) . There are a number of in vivo applications which can generally be grouped into three categories; (1) magnetic vectors guided to a certain location using a magnetic field (2) contrast agent in MRI and (3) hyperthermia agent for thermoablation ( Figure 3 ). Of important interest is their superparamagnetic properties which allow them to be used for drug delivery and also improved tissue and bone repair in tissue engineering. Growth factors can be attached to a magnetic carrier and guided to the site of a tissue engineering scaffold containing iron oxide nanoparticles which can improve tissue and bone repair (48) (49) (50) . It has also been shown that a static magnetic field can improve bone repair in rabbit models. This will be discussed in more detail in section 6.1. 
Drug Delivery
One of the major drawbacks with the use of chemotherapeutic drugs is the frequency and severity of side effects observed due to their systemic application.
IONPs are of interest for use in the targeted delivery of these, and other, drugs (51) (52) (53) . Drug delivery is a pharmaceutical approach to transporting drugs to a desired location in the body, often reducing the required dose. In general, magnetic
IONPs used for drug delivery consist of a core-shell structure with the IONPs as the core, coated in a biocompatible component (36) . The magnetic properties allow the pharmaceutically functionalised nanoparticles to be delivered to the site of interest by application of a magnetic field to a specific region of the body.
A further application in cancer therapies is in thermoablation where local overheating of the cancer cells can be achieved by hyperthermia (54).
Hyperthermia can be achieved due to the ability of magnetic nanoparticles to adsorb alternating current (AC) energy and convert it to heat (33) . By heating to a temperature between 41˚C and 46˚C thermal stress can cause the cancer cells to undergo apoptosis, a programmed cell death.
MRI contrast agent

Magnetic resonance imaging (MRI) is a non-invasive diagnostic technique which is
often the preferred imaging technique due to its high spatial resolution (~100nm), 
Nanoparticle-nanofibre composite fabrication
There are currently a number of different techniques employed to obtain iron oxide nanoparticle-nanofibre composites. These can be grouped into three categories; (1)pre-synthesised IONPs, (2) Post-treatment synthesised IONPs and The electrospinning process is generally unchanged with all particle synthesis techniques. If particles are pre-synthesised a co-electrospinning technique is generally employed where the nanoparticles are dispersed in a polymer solution before electrospinning. The other technique which can be used is coaxial electrospinning as discussed in section 3.
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Pre-synthesised nanoparticles
Electrospinning NPs which have already been synthesised is the most basic and therefore most commonly used technique for the fabrication of nanoparticlenanofibre composites. However, this process can often be multi-stage and time consuming requiring particles to be pre-synthesised and subsequently functionalised to reduce the effects of particle agglomeration and allow homogenous distribution throughout the nanofibres. In a recent study we have developed a novel one-stage in-situ synthesis technique to fabricate PEO and PVP nanofibres containing magnetite MNPs (28) . We have also demonstrated an ability to scale up the process from laboratory to industrial scale using a commercially available free-surface electrospinning set-up. In our technique a 2:1 molar ratio of ferric and ferrous chloride are added to a PEO solution in deionised water containing sodium borohydride, used to reduce the ions to nanoparticles. The reaction is allowed to progress before being electrospun ( Figure 4 ). Nanofibre mats were crosslinked using UV irradiation, EDX was used to confirm the presence of iron, DLS showed the average nanoparticle diameter to range from 8nm (PVP) to 26nm (PEO), XRD confirmed the phase of the nanoparticles to be magnetite and NMR showed a shortening in both T1 and T2 relaxation times confirming the nanoparticles could provide a suitable relaxation channel. 
Conclusion
There is a vast amount of research into potential scaffolds for tissue engineering. Reprinted with permission from [32] . 
